Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Topical Cadaveric-Derived Corneal Epithelial Stem Cell Transplant Therapy for the Treatment of Severe Dry Eye Disease

NCT03302273 is registered in ClinicalTrials.gov with Sloan W. Rush, MD as lead sponsor.

NCT NCT03302273
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03302273 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Topical Cadaveric-Derived Corneal Epithelial Stem Cell Transplant Therapy for the Treatment of Severe Dry Eye Disease
Lead sponsor
Sloan W. Rush, MD
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2019
Completion date
April 1, 2022
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blepharitis, dry eye, dry eye syndromes, ocular discomfort, ocular inflammation, ocular surface disease